Neurokinin A
Showing 1 - 25 of 141
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
Gynecologic Cancer Trial in Ann Arbor (Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA))
Recruiting
- Gynecologic Cancer
- Ondansetron
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jan 6, 2022
Prurigo Nodularis Trial in Germany (serlopitant, Placebo)
Menopausal Flushing Trial in London (NK3R antagonist - AZD4901, Placebo)
Completed
- Menopausal Flushing
- NK3R antagonist - AZD4901
- Placebo
-
London, United KingdomNIHR/Wellcome Trust Imperial CRF
Apr 7, 2021
Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus Trial in Lahore (NK-1R antagonist)
Unknown status
- Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus
- NK-1R antagonist
-
Lahore, Punjab, PakistanBahria International Hospital
Jul 10, 2020
Epidermolysis Bullosa, Pruritus Trial in Stanford (VPD-737, Placebo)
Migraine; Status Trial in Douliu (Acupressure elastic band (Sea-Band), General elastic band (no bud))
Completed
- Migraine; Status
- Acupressure elastic band (Sea-Band)
- General elastic band (no bud)
-
Douliu, Yunlin County, TaiwanNational Taiwan University Hospital Yunlin Branch
Jul 11, 2022
Functional Dyspepsia Trial in Rochester (Tradipitant, Placebo)
Not yet recruiting
- Functional Dyspepsia
- Tradipitant
- Placebo
-
Rochester, MinnesotaVanda Investigational Site
Dec 7, 2022
C.Surgical Procedure; Gastrointestinal Trial in Guangzhou (palonosteron, dexamethasone, and fosaprepitant dissolved in 0.9%
Completed
- C.Surgical Procedure; Gastrointestinal
- palonosetron, dexamethasone, and fosaprepitant dissolved in 0.9% NaCl
- palonosetron, dexamethasone, and 0.9% NaCl
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Dec 26, 2022
Hyperactivity, Allergic Rhinitis Due to House Dust Mite, Chronic Rhinosinusitis With Nasal Polyps Trial in Leuven (Cold, dry
Active, not recruiting
- Hyperactivity
- +2 more
- Cold, dry air
-
Leuven, BelgiumKULeuven
May 24, 2022
Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)
Not yet recruiting
- Nausea With Vomiting Chemotherapy-Induced
- Ondansetron every 3 weeks
- +3 more
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Oct 8, 2023
Chemo Induced Nausea and Vomiting Trial in Mount Olive (Akynzeo)
Recruiting
- Chemotherapy Induced Nausea and Vomiting
-
Mount Olive, AlabamaRudolph M Navari
Oct 8, 2023
Chemo-induced Nausea and Vomiting, Adverse Event, Cervical Cancer Trial in Odense (Akynzeo, Dexamethasone)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- +2 more
-
Odense, DenmarkDepartment of Oncology, Odense University Hospital
Dec 12, 2021
Aggression Trial in Hamilton (NK1 Antagonist, Placebo Oral Capsule)
Unknown status
- Aggression
- NK1 Antagonist
- Placebo Oral Capsule
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare Hamilton
Apr 18, 2019
Anorexia Nervosa Trial in Montpellier (Exposition Test)
Recruiting
- Anorexia Nervosa
- Exposition Test
-
Montpellier, FranceUniversity Hospital, Montpellier
Dec 31, 2021
Postoperative Nausea and Vomiting, Laparoscopic Cholecystectomy Trial in Tanta (Ondansetron 4mg + dexmedetomidine 0.5 ug/kg +
Recruiting
- Postoperative Nausea and Vomiting
- Laparoscopic Cholecystectomy
- Ondansetron 4mg + dexmedetomidine 0.5 ug/kg + normal saline .
- Ondansetron 4mg + dexamethasone 8mg + normal saline.
-
Tanta, Algharbia, EgyptTanta University hospitals
Aug 26, 2023
Opioid Use Disorder Trial in New York (Placebo, NT-814 50 mg, NT-814 100 mg)
Withdrawn
- Opioid Use Disorder
- Placebo
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Jul 31, 2020
Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage Trial in Guangzhou (Olanzapine Tablets, Placebo)
Recruiting
- Olanzapine
- +3 more
- Olanzapine Tablets
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Feb 14, 2022
Head Neck Cancer Trial in Berlin (SPRANC Block group, SPRANC Control group)
Suspended
- Head and Neck Cancer
- SPRANC Block group
- SPRANC Control group
-
Berlin, GermanyCharité Universitaetsmedizin Berlin
Jan 21, 2022
Postoperative Nausea and Vomiting, Anesthesia Complication, Thoracic Diseases Trial (Ondansetron 8mg, Fosaprepitant 150 mg)
Not yet recruiting
- Postoperative Nausea and Vomiting
- +2 more
- Ondansetron 8mg
- Fosaprepitant 150 mg
- (no location specified)
Jun 4, 2023
Gallbladder Cancer Trial in London (Shortened hydration time and dispensary of Akynzeo, Standard of care)
Recruiting
- Gallbladder Cancer
- Shortened hydration time and dispensary of Akynzeo
- Standard of care
-
London, United KingdomImperial College Healthcare NHS Trust
Jul 14, 2022
Breast Cancer Trial (use of a smartphone app for adverse event management, conventional adverse event management)
Not yet recruiting
- Breast Cancer
- use of a smartphone app for adverse event management
- conventional adverse event management
- (no location specified)
Feb 16, 2022
Chemo-induced Nausea and Vomiting (CINV) Trial (Granisetron transdermal patch, Palonosetron, Aprepitant)
Not yet recruiting
- Chemotherapy-induced Nausea and Vomiting (CINV)
- Granisetron transdermal patch
- +4 more
- (no location specified)
Jun 2, 2021